4//SEC Filing
TURKEL CATHERINE C. 4
Accession 0000899243-19-008141
CIK 0001404281other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:24 PM ET
Size
8.2 KB
Accession
0000899243-19-008141
Insider Transaction Report
Form 4
TURKEL CATHERINE C.
Chief Development Officer
Transactions
- Award
Common Stock
2019-03-14+20,000→ 98,199 total - Award
Stock Option (Right to Buy)
2019-03-14+50,000→ 50,000 totalExercise: $3.72Exp: 2029-03-14→ Common Stock (50,000 underlying)
Holdings
- 805(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]This represents restricted stock units representing the right to receive shares of the Issuer's Common Stock, which will vest in full on the later of achievement of a performance-related goal or the first anniversary of the grant date.
- [F2]This option represents a right to purchase a total of 50,000 shares of the Issuer's Common Stock, which will vest in equal quarterly installments through the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Documents
Issuer
Novus Therapeutics, Inc.
CIK 0001404281
Entity typeother
Related Parties
1- filerCIK 0001705278
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 4:24 PM ET
- Size
- 8.2 KB